Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients With Severe Vitamin D Deficiency: a Multicenter, Placebo-controlled Double-blind Phase III Randomized Controlled Trial (RCT)

NCT03188796 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT03188796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03188796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients With Severe Vitamin D Deficiency: a Multicenter, Placebo-controlled Double-blind Phase III Randomized Controlled Trial (RCT)
Lead sponsor
Medical University of Graz
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 10, 2017
Completion date
October 31, 2027
Enrollment
2,400 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, critical illness, vitamin d deficiency